249 related articles for article (PubMed ID: 29587844)
21. The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa.
Makepeace BL; Babayan SA; Lustigman S; Taylor DW
Expert Rev Vaccines; 2015; 14(9):1163-5. PubMed ID: 26091691
[TBL] [Abstract][Full Text] [Related]
22. THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?
El-Bahnasawy MM; Morsy AT; Morsy TA
J Egypt Soc Parasitol; 2015 Dec; 45(3):639-54. PubMed ID: 26939243
[TBL] [Abstract][Full Text] [Related]
23. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
24. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
25. Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
Rebollo MP; Zoure H; Ogoussan K; Sodahlon Y; Ottesen EA; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i14-i19. PubMed ID: 29471341
[TBL] [Abstract][Full Text] [Related]
26. Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.
Colebunders R; Stolk WA; Siewe Fodjo JN; Mackenzie CD; Hopkins A
Infect Dis Poverty; 2019 Oct; 8(1):83. PubMed ID: 31578157
[TBL] [Abstract][Full Text] [Related]
27. Research for new drugs for elimination of onchocerciasis in Africa.
Kuesel AC
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):272-286. PubMed ID: 27693536
[TBL] [Abstract][Full Text] [Related]
28. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
[TBL] [Abstract][Full Text] [Related]
29. Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness.
Globisch D; Moreno AY; Hixon MS; Nunes AA; Denery JR; Specht S; Hoerauf A; Janda KD
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4218-23. PubMed ID: 23440222
[TBL] [Abstract][Full Text] [Related]
30. Situation analysis of onchocerciasis in Cameroon: a protocol for systematic review of epidemiological studies and impact of disease control interventions.
Nana-Djeunga HC; Domche A; Niamsi-Emalio Y; Moungui HC; Walker M; Basáñez MG; Kamgno J
Syst Rev; 2020 Feb; 9(1):27. PubMed ID: 32046791
[TBL] [Abstract][Full Text] [Related]
31. Onchocerca volvulus: The Road from Basic Biology to a Vaccine.
Lustigman S; Makepeace BL; Klei TR; Babayan SA; Hotez P; Abraham D; Bottazzi ME
Trends Parasitol; 2018 Jan; 34(1):64-79. PubMed ID: 28958602
[TBL] [Abstract][Full Text] [Related]
32. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
[TBL] [Abstract][Full Text] [Related]
33. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
34. River blindness. Protection for 54 cents a year.
Vieta F
UN Chron; 1998; (1):12-3. PubMed ID: 12348635
[TBL] [Abstract][Full Text] [Related]
35. Neurological manifestations in Onchocerca volvulus infection: A review.
Hotterbeekx A; Namale Ssonko V; Oyet W; Lakwo T; Idro R
Brain Res Bull; 2019 Feb; 145():39-44. PubMed ID: 30458251
[TBL] [Abstract][Full Text] [Related]
36. Geospatial modeling of pre-intervention nodule prevalence of Onchocerca volvulus in Ethiopia as an aid to onchocerciasis elimination.
Shrestha H; McCulloch K; Hedtke SM; Grant WN
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010620. PubMed ID: 35849615
[TBL] [Abstract][Full Text] [Related]
37. WHO celebrates triumph over river blindness.
Ciment J
BMJ; 1999 Oct; 319(7217):1090. PubMed ID: 10531090
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
39. Establishing quality assured (QA) laboratory support for onchocerciasis elimination in Africa.
Shott J; Ducker C; Unnasch TR; Mackenzie CD
Int Health; 2018 Mar; 10(suppl_1):i33-i39. PubMed ID: 29471345
[TBL] [Abstract][Full Text] [Related]
40. The elusive elimination of river blindness.
Burki T
Lancet Infect Dis; 2021 Feb; 21(2):175-176. PubMed ID: 33515523
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
